Back to search
Refractory Immune-related Cytopenia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Immune-related Cytopenia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Immune-related Cytopenia trials you may qualify forThis is a single-arm, open-label，phase I clinical study to evaluate the safety and tolerability of Inaticabtagene Autoleucel Injection in treatment of refractor…
The objective of this study is to evaluate the efficacy and safety of BCMA/CD19 chimeric antigen receptor (CAR)-modified T cells in the treatment of autoimmune…
This study aims to utilize anti-CD20 monoclonal antibodies to eliminate peripheral B cells and reduce the mechanism of autoantibody production, as well as combi…
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Peripheral stem cell transplantation ma…
The purpose of this study is to understand physician treatment decisions in selecting specific second line treatments in pediatric ITP and to determine the effe…